Willingness to participate in clinical trials among patients of Chinese heritage: a meta-synthesis.

dc.contributor.author

Limkakeng, Alexander

dc.contributor.author

Phadtare, Amruta

dc.contributor.author

Shah, Jatin

dc.contributor.author

Vaghasia, Meenakshi

dc.contributor.author

Wei, Ding Ying

dc.contributor.author

Shah, Anand

dc.contributor.author

Pietrobon, Ricardo

dc.contributor.editor

Cameron, D William

dc.date.accessioned

2018-05-07T23:54:02Z

dc.date.available

2018-05-07T23:54:02Z

dc.date.issued

2013-01-17

dc.date.updated

2018-05-07T23:54:01Z

dc.description.abstract

BACKGROUND: Subjects of Chinese heritage have been found to participate in clinical research at lower rates than other groups despite growing in numbers as a population. While much research has examined research participants' motivation, there has not been a comprehensive synthesis of this information with respect to participants of Chinese descent. We sought to identify the factors that promote and hinder participation in clinical research among participants of Chinese heritage. METHODOLOGY/PRINCIPAL FINDINGS: We conducted a systematic review of the literature in Pubmed, OpenJGATE, SCIRUS, and COCHRANE databases and performed a meta-synthesis of retrieved articles. We extracted qualitative data, such as quotes to identify emerging themes. We identified five studies that met our selection criteria. Of them, only one (1/5) was conducted in China while other studies involved Chinese emigrants in USA (3/5) and Singapore (1/5). Participants from China were similar to emigrants with regard to factors that either promoted or decreased research participation. Four studies reported data exclusively on Chinese subjects. Three of the five studies involved qualitative interviews while the others were conducted using a survey design. Six themes favoring research participation were identified: Personal Benefit to Participants, Financial Incentives, Participant Sense of Altruism, Family or Physician Recommendations, Advertisements, and Convenience to the Participant. Five factors were seen as a barrier to participation in clinical trials: Mistrust of Researchers, Language Barrier, Lack of Financial and Other Support, Cultural and Social Barriers, Lack of Knowledge about Clinical Trials. CONCLUSIONS/SIGNIFICANCE: Chinese heritage clinical research participants value personal benefit, financial incentives, the ability to help others, recommendations of others, advertisements, and convenience when considering clinical research participation. In addition, the establishment of trust and addressing knowledge deficits are important factors to them. Investigators seeking to optimize enrolment in these populations should incorporate these findings into their study design and subject handouts.

dc.identifier.issn

1932-6203

dc.identifier.issn

1932-6203

dc.identifier.uri

https://hdl.handle.net/10161/16689

dc.language

eng

dc.publisher

Public Library of Science (PLoS)

dc.relation.ispartof

PloS one

dc.relation.isversionof

10.1371/journal.pone.0051328

dc.subject

Humans

dc.subject

Attitude to Health

dc.subject

Language

dc.subject

Social Behavior

dc.subject

Asian Continental Ancestry Group

dc.subject

Advertising as Topic

dc.subject

Clinical Trials as Topic

dc.title

Willingness to participate in clinical trials among patients of Chinese heritage: a meta-synthesis.

dc.type

Journal article

duke.contributor.orcid

Limkakeng, Alexander|0000-0002-9822-5595

pubs.issue

1

pubs.organisational-group

School of Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Surgery, Emergency Medicine

pubs.organisational-group

Surgery

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Faculty

pubs.publication-status

Published

pubs.volume

8

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Willingness to participate in clinical trials among patients of Chinese heritage: a meta-synthesis.pdf
Size:
244.56 KB
Format:
Adobe Portable Document Format
Description:
Accepted version